






Microalbuminuria is an early manifestation
of HIV associated nephropathy (HIVAN). This study was
to determine the prevalence and risk factors for
microalbuminuria in children with HIV infection in Port
Harcourt, Nigeria
: Urine specimen of 50 children with HIV
infection seen over a 4months period (October 2007-
February 2008) was assayed for albumin and creatinine
to determine urinary albumin to creatinine ratio (ACR).
Microalbuminuria was defined as urinary albumin to
creatinine ratio (ACR) of greater than 2.5 -25mg/mmol.
The glomerular filtration rate (GFR) was calculated using
the Schwartz formula.
: There were 28 (56%) males and 22 (44%)
females with a male to female ratio of 1.3:1. They aged 1
month to 18 years with a mean age of 4.07 ± 3.61years.
Microalbuminuria occurred in 6 (12%) patients; 3 males
and 3 females, mean age of 5.5 ± 4.6 years. Five (83.3%)
of the patients with microalbuminuria had clinical AIDS
and CD4 cell count 0cells/ L. All the
patients with microalbuminuria were not receiving highly
active antiretroviral therapy (HAART) at the time of study.
One (16.7%) patient had overt HIV-associated
nephropathy (HIVAN) with ACR greater than 2.5
mg/mmol, elevated serum creatinine 400µmmo/L, urea of
20mmol/Land a GFR of 69ml/min/1.73m .
: The prevalence of microalbuminuria in
Nigerian children with HIV infection is high, and it occurs
mainly in older children with clinical AIDS who are not on
HARRT.
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Introduction
Since the early years of HIV epidemic, renal disease has
been increasingly recognized as a significant cause of
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morbidity and mortality in patient with human
immunodeficiency virus (HIV) infection . Renal
involvement in HIV infection results from either the
direct effect of the virus on the renal epithelium,
opportunistic infections, immune complex deposition or
from the side effect of medications used to treat HIV
infection or opportunistic infections . The broad
spectrum of clinical presentation includes acute renal
failure, HIV associated nephropathy (HIVAN), nephrotic
syndrome, tubular functional abnormalities and
electrolyte disorders . HIVAN is the most common
renal disease in HIV seropositive patients       . It has
been widely reported in children with HIV
infection          . The characteristic features of HIVAN
are proteinuria and rapidly deteriorating renal function
. Most published reports described heavy proteinuria in
children with HIV infection          . Studies carried out in
the United States of America (USA) reported that
proteinuria is present in approximately 30% of patients
with HIV infection . Although, microalbuminuria has
been reported to be an early manifestation of
HIVAN       . Microalbuminuria is a subclinical condition
that is associated with high morbidity and mortality and a
well recognized risk indicator for renal disease       .
The present study was carried out to determine the
prevalence and risk factors for microalbuminuria in
children with HIV infection in our hospital. This is to
enable intervention measures to enhance early
detection of HIVAN and effect prompt treatment to
prevent rapid progression to end stage renal disease
(ESRD).
This was a single center prospective pilot study
conducted in the Infectious Disease Clinic (IDC) of the
department of Paediatrics, University of Port Harcourt
Teaching Hospital (UPTH). The Hospital is the only
tertiary and referral centre in Port Harcourt, capital of
Rivers State of Nigeria. Most patients are self -referred,
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hospital cares for children with HIV infection in the
Infectious Disease Unit (IDU). During the period of study,
there were 180 registered HIV infected children attending
the IDC.
We prospectively studied children with HIV infection aged
1 month to 18 years over a period of 4 month from October
2007 to February 2008. The HIV status of the children was
confirmed with the Western blot Proviral DNA method.
Information on the biodata, clinical data, mode of
transmission of HIV infection, CD4 cell count and drug
medication were entered into a questionnaire that was
used for each patient. Early morning urine specimens
were collected from the subjects into a universal bottle and
submitted to the laboratory within two hours of collection.
Specimens were stored at 4 C and batch analyzed within
one week of collection. Cloudy specimens were
centrifuged and the supernatants were used for the assay.
Urine albumin was assayed by immunoturbidimetry
(Randox Laboratories UK Antrim). Urinary and serum
creatinine were determined by the Jaffe Kinetic method
(Biolabo SA Maizy, France). Absorbances were read in a
Jenway 6320D spectrophotometer. Routine laboratory
precision and accuracy controls were utilized. The urinary
albumin to creatinine ratio (ACR) was determined by
dividing the albumin concentration by the creatinine
concentration. Results were expressed in milligram per
millimole (mg/mmol). Microalbuminuria was defined as
ACR of 2.5-25 mg/mmol. The glomerular filteration rate
(GFR) was calculated using the Schwartz formula [height
(cm) × 0.55/serum creatinine (mg/dl)]  .
Fifty patients with HIV infection aged 1 month to 18 years
(mean 4.07 ± 3.61 years) were studied. There were 28
(56%) males and 22 (44%) females with a male to female
ratio of 1.3:1. The modes of transmission of HIV infection
were vertical in 47 (94%) patients; blood transfusion in 2
(4%) patients and from unsterilized objects used for
scarification mark in 1 (2%) patient. Only 7 (14%) were on
highly active antiretroviral therapy (stavudine 1mg/kg
twice daily; nevirapine 2mg/kg once daily for 2 weeks,
then increased to 4mg/kg twice daily and lamivudine
4mg/kg twice daily ). The mean serum creatinine and urea
were 67.5 mmol/L (range 40-400 mmol/L) and 4.1m mol
/L (range 1.2-20mmol/L) respectively. The mean
glomerular filtration rate (GFR) was 100ml/min/1.73m
(range 69-125ml/min/1.73m
Microalbuminuria occurred in 6 (12%) patients; 3 males
and 3 females with mean age of 5.5± 4.6years. Although,
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was not statistically significant (P>0.2). One (16.7%)
patient had overt HIVAN with ACR of 15 mg/mmol,
elevated serum urea and creatinine of 20mmol/L and
400µmmo/L respec t i ve l y and a GFR o f
69ml/min/1.73m . The remaining 5 (83.3%) patients had
normal serum urea, creatinine and GFR. Clinical AIDS
((persistent diarrhea, weight loss greater than 10%,
chronic cough, oral candidiasis and skin rash) and low
CD4 cell count of less than 200 was seen in 5
(83.3%) patients. The mode of transmission of HIV
infection in all the patients with microalbuminuria was
vertical. None had received highly active antiretroviral
therapy (HAART) at the time of study.
The prevalence of overt proteinuria in patients with HIV
infection has been widely published both in
adults and in children . However, there are
yet few published reports on the prevalence of
microalbuminuria in HIV seropositive patients . In our
present study, the 12% prevalence of microalbuminuria
in HIV infected children is comparable to 11.1%
prevalence reported by Leroy et al in children in USA
and the 11% prevalence reported by Szczech et al in
adults also in USA. However, it was lower than the 64%
prevalence reported by Han et al in HIV seropositive
adults in South Africa, a similar African country.
Although HIVAN have been reported to occur in
younger children from 30 months of age  , we found
microalbuminuria more in older children. This is similar
to the findings of Chaparro et al where proteinuria was
found only in older children with mean age of 8.7years.
Most published studies agree that HIVAN is a late
manifestation of HIV infection . The finding of
microalbuminuria in older patients in our study although
not statistical significant may suggest that the risk for
HIVAN is greatest in those with longer duration of HIV
infection since all the patients acquired the infection
perinatally. Although HIVAN has been reported to be
more prevalent in males there was no significant sex
difference in those children with microalbuminuria in this
present study.
Microalbuminuria is a sign of early damage to the
kidneys and cardiovascular system . Individuals with
microalbuminuria may have a rapid progression to overt
proteinuria, progressive deterioration in renal function
and may eventually develop end stage renal disease
(ESRD)  . Some studies have noted that HIVAN
progress to ESRD at a very rapid rate, varying form
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al noted a less fulminant course in children. In our
present study, all except one of the patients with
microalbuminuria had normal renal function. This will
suggest that Nigerian children with HIVAN may have a
slower progression to ESRD.
The major i ty (83.3%) of the pat ients wi th
microalbuminuria including the one with overt HIVAN had
AIDS in clinical stage 3 as defined by the World Health
Organization (WHO) with severe immunosuppression.
This is similar to the findings of Chaparro et al where
32.2% of the patients with proteinuria were in advanced
stages ofAIDS.
Highly active antiretroviral therapy (HAART) and
angiotensin-converting enzyme inhibitors (ACEI) are
standard therapeutic regimen for the treatment of HIVAN
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efficacy of zidovudine alone and HAART in slowing
progression to ESRD in patients with HIVAN .
However, Michel et al suggested that the efficacy of
zidovudine in preventing renal failure in HIVAN patients
is greatest when started before the onset of renal failure.
In our present study, all 6 patients with microalbuminuria
were yet to commence HAART at the time of study. Early
commencement of zidovudine and ACEI may be
beneficial in slowing the progression to ESRD in those
patients with normal renal function.
In conclusion, the prevalence of microalbuminuria is
high in Nigerian children with HIV infection. It occurred
mainly in older children with clinical AIDS who are not
receiving HAART. We recommend routine screening for
microalbuminuria in HIV infected patients and early
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